Regulatory Eli Lilly wins FDA approval for weight loss pill, tees up Novo rivalry Pharmaceutical TechnologyLilly's product, known under the brand name Foundayo, has a clear route to early blockbuster status.RegulatoryMetabolic & GLP-1Read full story pharminent April 2, 2026 (Last updated: April 2, 2026) Pharmaceutical Technology Lilly’s product, known under the brand name Foundayo, has a clear route to early blockbuster status. RegulatoryMetabolic & GLP-1Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Building What’s Next: Join Industry Leaders to Shape Access and Affordability Trends Ahead of Asembia AXS26Next: ACC 2026: Meta-analysis supports CagriSema as superior first-line therapy in obesity Related Stories Regulatory FDA approves MSD’s Keytruda combinations for MIBC pharminent July 13, 2026 Regulatory FDA freezes CRL trove as ‘radical transparency’ push hits speedbump pharminent July 9, 2026 Regulatory UK first in Europe to clear Boehringer’s IPF drug Jascayd pharminent July 9, 2026
